Results from the Veterans Affairs Diabetes Trial showed that PAI-1 was an independent risk factor for DR incidence in T2DM patients, specifically, a 12% greater risk of developing DR for each 10 ng/dL rise in the baseline serum PAI-1 level [74]. This evidence concerns the gene SERPINE1 and type 2 diabetes mellitus.